Intercept Pharmaceuticals Inc


Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …

Intercept Pharmaceuticals Inc (ICPT) Comments on Ocaliva Safety and Dosing

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare Provider (DHCP) letter issued on September 12, 2017, …

Top Analyst Cuts Price Target For Intercept Pharmaceuticals Inc (ICPT) By 50%; Here’s Why

Intercept Sank 40% in September following Dear Doctor and FDA warning letters; Ritu Baral weighs in.

Intercept Pharmaceuticals Inc (ICPT) Investors Run for the Hills; Here’s Why

Shares of drug maker Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are in a freefall today. Why?

Top Analyst Shines Light on Intercept Pharmaceuticals Inc’s (ICPT) Dear Health Care Provider Letter

Dear doctor: My shares just fell 15%.

Intercept Pharmaceuticals Inc (ICPT) Announces Clinical Results in Fibrosis

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) announced results from CONTROL, a placebo-controlled trial to prospectively characterize the lipid metabolic effects of obeticholic acid (OCA) and …

Intercept Pharmaceuticals Inc (ICPT) Announces Q1:17 Results; Shares Climb 9%

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended March 31, 2017 and provided other general business updates. “I’m very …

This Analyst Bullish On Intercept Pharmaceuticals Inc (ICPT) Long-Term

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares rose as much as 9% during Friday’s trading session, after the drug maker announced changes to its ongoing Ocaliva …

Stock Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Receives Granted Conditional Approval for Ocaliva from EU for the Treatment of Primary Biliary Cholangitis

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) announced that the European Commission has granted conditional approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts